Exploration of therapeutic targets for sexual dysfunctions: lessons learned from the failed stories

Author： Abdel-Hamid Ibrahim A Andersson Karl-Erik Salonia Andrea

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.3, 2011-03, pp. : 325-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Therapeutic Targets for Neurodegenerative Diseases: Lessons Learned from Calorie Restriction

Current Drug Targets, Vol. 11, Iss. 10, 2010-10 ,pp. : 1281-1292

Bentham Science Publishers

Access to resources Recommend Favorite

Lessons learned from development of docetaxel

By Strother Robert Matthew Sweeney Christopher

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 1007-1019

Informa Healthcare

Access to resources Recommend Favorite

Losartan: lessons learned from the RENAAL study

By Shahinfar Shahnaz Lyle Paulette A Zhang Zhongxin Keane William F Brenner Barry M

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 623-630

Informa Healthcare

Access to resources Recommend Favorite

Lessons Learned from the Irinotecan Metabolic Pathway

Current Medicinal Chemistry, Vol. 10, Iss. 1, 2003-01 ,pp. : 41-49

Bentham Science Publishers

Access to resources Recommend Favorite

Trends in the Exploration of Therapeutic Targets for the Treatment of Endocrine, Metabolic and Immune Disorders

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 3, 2007-09 ,pp. : 225-231

Bentham Science Publishers

Access to resources Recommend Favorite